Holley Group

Holley Group is a prominent Chinese conglomerate with a core focus on the pharmaceutical and healthcare sectors, particularly known for its global leadership in the artemisinin industry. The company manages a comprehensive supply chain for anti-malarial drugs, from the cultivation of Artemisia annua to the production of active pharmaceutical ingredients and finished formulations. Through its listed subsidiaries, including Kunming Pharmaceutical Group and Wuhan Jianmin Pharmaceutical, Holley Group offers a diverse portfolio of Traditional Chinese Medicines and modern pharmaceuticals targeting cardiovascular and neurological conditions. The group's healthcare division is complemented by its activities in medical instruments and international trade, making it a significant player in the global health market. Holley Group is recognized as the world's largest producer of artemisinin, contributing significantly to global malaria eradication efforts.